These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7915079)

  • 1. [c-erbB-2 oncogene product expression in lacrimal gland tumors].
    Tosaka Y; Ishimoto K; Sawaguchi S; Sekiya M
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):704-9. PubMed ID: 7915079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical study of pleomorphic adenoma of the lacrimal gland].
    Tosaka Y; Fujii S
    Nippon Ganka Gakkai Zasshi; 1990 Mar; 94(3):307-13. PubMed ID: 2168672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical features of lacrimal gland epithelial tumors.
    Mendoza PR; Jakobiec FA; Krane JF
    Am J Ophthalmol; 2013 Dec; 156(6):1147-1158.e1. PubMed ID: 23972314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of pleomorphic adenoma of lacrimal gland.
    Tosaka Y
    Jpn J Ophthalmol; 1991; 35(4):367-76. PubMed ID: 1668241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression of MMP-2 and MMP-9 in adenoid cystic carcinoma of lacrimal gland].
    Zhang L; Zhang H; Song GX; Lin TT; Xu GC; Zhu LM
    Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):58-63. PubMed ID: 23601468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker.
    Mulay K; Puthyapurayil FM; Mohammad JA; Hasnat Ali M; Honavar SG; Reddy VA
    Histopathology; 2013 May; 62(6):840-6. PubMed ID: 23611357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1ɑ) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome.
    Anjum S; Sen S; Chosdol K; Bakhshi S; Kashyap S; Pushker N; Bajaj MS; Meel R; Sharma MC
    Ann Diagn Pathol; 2022 Feb; 56():151846. PubMed ID: 34749048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative analyses of DNA content and P53 gene product expression from epithelial lacrimal gland tumors].
    Zhao P; Sun X
    Zhonghua Yan Ke Za Zhi; 1996 Nov; 32(6):424-8. PubMed ID: 9590808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.
    Anjum S; Sen S; Pushker N; Bajaj MS; Kashyap S; Bakhshi S; Chosdol K; Meel R; Sharma MC
    Acta Ophthalmol; 2021 Dec; 99(8):e1467-e1473. PubMed ID: 33675181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of metabolism-related proteins in lacrimal gland adenoid cystic carcinoma.
    Koo JS; Yoon JS
    Am J Clin Pathol; 2015 Apr; 143(4):584-92. PubMed ID: 25780012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.
    Chen TY; Keeney MG; Chintakuntlawar AV; Knutson DL; Kloft-Nelson S; Greipp PT; Garrity JA; Salomao DR; Garcia JJ
    Eye (Lond); 2017 May; 31(5):720-725. PubMed ID: 28085142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between expression of P21ras and cellular DNA in pleomorphic adenoma of lacrimal gland].
    Zheng L; He S; Fan Z; Han C
    Yan Ke Xue Bao; 1996 Jun; 12(2):54-7. PubMed ID: 9639847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on expression of epidermal growth factor receptor in pleomorphic adenoma of lacrimal gland].
    Zheng L; Fan Z; He S
    Zhonghua Yan Ke Za Zhi; 1995 May; 31(3):212-4. PubMed ID: 7555406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic and nuclear leptin expression in lacrimal gland tumours: a pilot study.
    Kim YJ; Kim YS; Chin S; Yoon JS; Lee SY; Kim CY; Jang SY
    Br J Ophthalmol; 2015 Sep; 99(9):1306-10. PubMed ID: 25995297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ribosomal protein L39-L in the drug resistance mechanisms of lacrimal gland adenoid cystic carcinoma cells.
    Ye Q; Ding SF; Wang ZA; Feng J; Tan WB
    Asian Pac J Cancer Prev; 2014; 15(12):4995-5000. PubMed ID: 24998577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic review of epithelial tumors of the lacrimal gland.
    Chawla B; Kashyap S; Sen S; Bajaj MS; Pushker N; Gupta K; Chandra M; Ghose S
    Ophthalmic Plast Reconstr Surg; 2013; 29(6):440-5. PubMed ID: 24145905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant tumors of the lacrimal gland--a report of 27 cases].
    Wu Z; Pan Y; Liu J; Li L; Mo Y
    Yan Ke Xue Bao; 1991 Jun; 7(2):98-102. PubMed ID: 1668881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.